ISHARES INC - US INTL HGH YLD (GHYG)

Historical Holders from Q1 2014 to Q3 2025

Symbol
GHYG
Type / Class
Equity / US INTL HGH YLD
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,898,940
Holdings value
$134,897,610
% of all portfolios
0.001%
Number of holders
41
Number of buys
20
Number of sells
-17
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ISHARES INC - US INTL HGH YLD (GHYG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2,898,940 $134,897,610 +$9,481,653 $46.54 41
2025 Q2 2,695,324 $124,832,518 -$9,425,194 $46.31 45
2025 Q1 2,901,978 $129,322,314 +$22,416,069 $44.56 47
2024 Q4 2,403,608 $105,954,611 -$1,217,652 $44.07 45
2024 Q3 2,342,529 $107,212,150 +$2,745,212 $45.78 50
2024 Q2 2,285,814 $99,925,370 +$8,554,778 $43.71 49
2024 Q1 2,078,362 $91,747,439 -$220,429 $44.15 48
2023 Q4 1,892,561 $83,704,155 -$16,001,160 $44.23 45
2023 Q3 2,254,584 $93,617,744 +$9,770,146 $41.51 47
2023 Q2 1,928,831 $81,928,238 -$10,733,580 $42.48 44
2023 Q1 2,181,200 $93,383,988 +$31,929,354 $42.82 39
2022 Q4 1,435,646 $59,434,797 -$9,267,045 $41.4 30
2022 Q3 1,768,346 $68,807,418 +$20,559,732 $38.92 28
2022 Q2 1,241,824 $50,453,126 -$14,387,337 $40.63 31
2022 Q1 1,562,067 $74,262,232 -$24,192,990 $46.16 33
2021 Q4 2,193,213 $108,176,710 -$11,746,076 $49.29 37
2021 Q3 2,211,564 $110,705,984 +$3,353,853 $50.05 37
2021 Q2 2,144,519 $109,090,436 +$8,075,107 $50.86 38
2021 Q1 1,987,473 $99,769,898 +$7,766,038 $50.19 38
2020 Q4 1,832,321 $92,946,488 +$7,271,691 $50.73 35
2020 Q3 1,688,954 $81,101,299 +$11,445,864 $48.02 32
2020 Q2 1,457,339 $67,387,852 -$5,336,332 $46.27 33
2020 Q1 1,588,295 $67,138,000 -$10,682,886 $42.28 34
2019 Q4 1,736,474 $86,524,000 -$4,341,025 $49.83 43
2019 Q3 1,822,934 $88,930,428 -$1,146,150 $48.79 41
2019 Q2 1,847,185 $91,073,000 +$15,087,608 $49.33 39
2019 Q1 1,528,017 $74,643,000 -$16,815,645 $48.83 42
2018 Q4 1,866,543 $85,937,000 -$27,812,359 $46.03 43
2018 Q3 2,430,963 $120,395,000 +$12,294,756 $49.53 45
2018 Q2 2,182,827 $106,934,000 +$3,846,456 $48.99 48
2018 Q1 2,100,070 $105,286,000 +$14,869,968 $50.12 50
2017 Q4 1,802,515 $90,942,000 -$8,709,754 $50.45 42
2017 Q3 1,897,861 $97,585,000 +$20,081,825 $51.42 33
2017 Q2 1,553,641 $78,445,000 -$3,339,190 $50.49 34
2017 Q1 1,620,045 $79,952,000 +$39,887,125 $49.36 31
2016 Q4 814,365 $39,481,000 -$7,821,623 $48.48 29
2016 Q3 972,093 $48,098,000 -$10,365,709 $49.49 26
2016 Q2 1,202,199 $57,233,000 +$4,988,122 $47.61 30
2016 Q1 1,092,491 $50,449,000 -$4,753,338 $46.18 21
2015 Q4 1,197,390 $53,489,918 +$5,146,411 $44.62 28
2015 Q3 1,083,109 $50,592,000 +$18,301,616 $46.72 20
2015 Q2 884,217 $43,804,278 -$847,390 $49.54 25
2015 Q1 901,345 $44,564,680 +$8,043,627 $49.45 23
2014 Q4 740,382 $36,823,306 +$34,624,306 $49.73 26
2014 Q3 240 $12,000 -$1,137,000 $50 1
2014 Q2 20,935 $1,149,000 $54.9 2
2014 Q1 20,935 $1,138,000 +$186,000 $54.39 2